SEC Comment Letter 0000000000-23-011447 to BIO KEY INTERNATIONAL INC (BKYI)
BIO KEY INTERNATIONAL INC
Date: Oct. 19, 2023 · CIK: 0001019034 · Accession: 0000000000-23-011447
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-275003
Letter
United States securities and exchange commission logo October 19, 2023 Michael DePasquale Chief Executive Officer BIO-key International, Inc. 101 Crawfords Corner Road Suite 4116 Holmdel, NJ 07733 Re:BIO-key International, Inc. Registration Statement on Form S-1 Filed October 16, 2023 File No. 333-275003 Dear Michael DePasquale: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Austin Pattan at 202-551-6756 with any questions. Sincerely, Division of Corporation Finance Office of Technology cc: Vincent Vietti
Show Raw Text
United States securities and exchange commission logo
October 19, 2023
Michael DePasquale
Chief Executive Officer
BIO-key International, Inc.
101 Crawfords Corner Road
Suite 4116
Holmdel, NJ 07733
Re:BIO-key International, Inc.
Registration Statement on Form S-1
Filed October 16, 2023
File No. 333-275003
Dear Michael DePasquale:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Austin Pattan at 202-551-6756 with any questions.
Sincerely,
Division of Corporation Finance
Office of Technology
cc: Vincent Vietti